Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

New technologies show promise in healing wounds, treating cancer, autoimmune diseases, and genetic disorders.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Disodium folinate can safely and effectively replace calcium folinate in colorectal cancer treatment.

Calancardin B may help reduce inflammation in immune cells.

Dutasteride and minoxidil helped regrow hair in a woman with breast cancer.

Targeting SOX proteins may improve cancer treatment by restoring immune function.

Natural products can help overcome cancer drug resistance.

A special gel with medicine helps prevent melanoma from coming back after surgery.

Targeted photodynamic therapy is a promising method for precise disease treatment and diagnosis.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.

TS-13 speeds up hair regrowth after chemotherapy.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Licorice root-derived nanoparticles target liver cancer cells to improve treatment and reduce side effects.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Core symptoms in breast cancer chemotherapy remain stable, aiding targeted interventions.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Lower doses of topotecan are safe for eyes, but higher doses may harm the retina.

New nanocarriers improve skin drug delivery with low toxicity at certain concentrations.

Transethosomal gels improve naftifine skin delivery better than Exoderil cream.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.